Management strategies for tacrolimus overdoses are crucial, indicating potential complications with nirmatrelvir and ritonavir.
Journal Article Accepted manuscript Let's not make things worse in the management of tacrolimus overdoses due to nirmatrelvir/ritonavir Get access Florian Lemaitre, PharmD, PhD, Florian Lemaitre, PharmD, PhD Univ Rennes, CHU Rennes, INSERM, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMRS 1085, RennesINSERM, Clinical Investigation Center 1414, RennesFHU SUPORT, Rennes, France https://orcid.org/0000-0002-0908-3629 Search for other works by this author on: Oxford Academic Google Scholar Rémi Balluet, PharmD, PhD, Rémi Balluet, PharmD, PhD Laboratoire de Pharmacologie-Toxicologie-Gaz du Sang, CHU de Saint-Etienne, Saint-Etienne, France Email: [email protected] Search for other works by this author on: Oxford Academic Google Scholar Valentine Poinot Valentine Poinot Laboratoire de Pharmacologie-Toxicologie-Gaz du Sang, CHU de Saint-Etienne, Saint-Etienne, France Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, zxaf242, https://doi.org/10.1093/ajhp/zxaf242 Published: 04 September 2025 Article history Received: 11 February 2025 Accepted: 04 September 2025 Published: 04 September 2025
No takes yet. Share an insight, caveat, or question.
Lemaı̂tre et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: